| Journal | Frontiers in cellular neuroscience |
| Study Type | Clinical Study |
| Population | Human participants |
This research illuminates why some patients develop anxiety disorders after stress exposure while others remain resilient, potentially informing personalized treatment approaches. Understanding the brain-immune-endocannabinoid interactions in stress response could guide targeted interventions for vulnerable patients.
This review examines individual variability in stress responses, focusing on the interplay between the HPA axis, immune function, and endocannabinoid signaling in anxiety disorder development. The authors explore how chronic stress leads to sustained HPA activation, amygdala hyperreactivity, and immune dysfunction, while discussing potential biomarkers including amygdala reactivity, cortisol levels, and sleep disturbances as predictors of stress vulnerability. The study emphasizes the endocannabinoid system’s role in modulating stress resilience through its effects on HPA axis regulation and immune responses.
“While this framework elegantly connects stress neurobiology to clinical anxiety presentations, I remain cautious about biomarker-driven treatment selection until we have validated clinical tools. The endocannabinoid system’s central role here reinforces what I observe clinically—that cannabis medicine often helps patients with stress-related anxiety, likely through these same regulatory pathways.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What does this review say about why stress affects people differently?
It examines individual variability in stress responses, focusing on how the HPA axis, immune function and endocannabinoid signaling interact in the development of anxiety disorders. The aim is to help explain why some people develop anxiety disorders after stress exposure while others remain resilient, which could potentially inform more personalized treatment approaches.
How does chronic stress affect the brain and immune system?
According to the review, chronic stress leads to sustained activation of the HPA axis, hyperreactivity of the amygdala and immune dysfunction. The authors explore these changes in the context of how anxiety disorders develop after stress.
Are there biomarkers that could predict who is vulnerable to stress?
The review discusses several potential biomarkers of stress vulnerability: amygdala reactivity, cortisol levels and sleep disturbances. They are presented as possible predictors of who may be more vulnerable to stress, rather than as established tests.
How is the endocannabinoid system involved in stress resilience?
The review emphasizes that the endocannabinoid system plays a role in modulating stress resilience. It does so through its effects on regulation of the HPA axis and on immune responses, the same brain and immune pathways the authors connect to the development of anxiety disorders.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
